Brief: Lipocine Q1 EPS USD -0.54
07/05/2026 21:05
May 07 (Reuters) - Lipocine Q1 basic EPS USD -0.54. Q1 net income USD -3.7 million
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy